<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26093" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Occipital Nerve Stimulation</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sakharpe</surname>
            <given-names>Ashish K.</given-names>
          </name>
          <aff>Augusta University Medical Center</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cascella</surname>
            <given-names>Marco</given-names>
          </name>
          <aff>Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, Via Mariano Semmola 80100, Napoli. Italy</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Ashish Sakharpe declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marco Cascella declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>3</day>
          <month>7</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26093.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Occipital nerve stimulation is a neuromodulation technique used for the treatment of refractory primary and secondary headache disorders. This activity reviews the indications, contraindications, technique, and complications of occipital nerve stimulation and highlights the role of the interprofessional team to provide well-coordinated care to patients with an occipital nerve stimulator.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the anatomical structures, indications, and contraindications of occipital nerve stimulation.</p></list-item><list-item><p>Describe the equipment, personnel, preparation, and technique in regards to occipital nerve stimulation.</p></list-item><list-item><p>Outline potential complications and clinical significance of occipital nerve stimulation.</p></list-item><list-item><p>Review interprofessional team strategies for improving care coordination and communication using occipital nerve stimulation to improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26093&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26093">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26093.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Occipital nerve stimulation (ONS) is a neuromodulation technique&#x000a0;aimed at&#x000a0;the treatment of different types of neuralgia. This minimally invasive adjustable, and reversible approach provides an implantable device composed of a subcutaneous regional electrode and a pulse generator. It was first described by Picaza et al., in 1977,&#x000a0;and thus performed on&#x000a0;13 patients&#x000a0;by Weiner and Reed in 1999 for the &#x0201c;control of intractable occipital neuralgia.&#x0201d;<xref ref-type="bibr" rid="article-26093.r1">[1]</xref><xref ref-type="bibr" rid="article-26093.r2">[2]</xref>&#x000a0;From this first application, possible indications of ONS have expanded to various primary and secondary headache disorders not responsive to other therapies, including drugs for neuropathic pain, infiltrations (e.g., corticosteroids), radiofrequency rhizolysis, acupuncture, psychobehavioral approaches, and different multidisciplinary strategies.<xref ref-type="bibr" rid="article-26093.r3">[3]</xref><xref ref-type="bibr" rid="article-26093.r4">[4]</xref><xref ref-type="bibr" rid="article-26093.r5">[5]</xref><xref ref-type="bibr" rid="article-26093.r6">[6]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-26093.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>The nerves that innervate the occipital area includes the greater (a branch of C2 spinal root), lesser (a branch of C2 and C3 spinal root), and least occipital nerve (a medial branch of the posterior division of C3). The greater occipital is the largest pure sensory nerve and provides sensory innervation to the skin of the posterior skull, occipital, and temporal area. It&#x000a0;is closely associated with the occipital artery at the exit site. The lesser occipital nerve is a cutaneous branch that provides sensory innervation to the skin of the upper and back part of the auricle. The least occipital nerve lies medial to greater occipital nerve and supplies C2-C3 zygapophyseal joint, part of semispinalis capitis, and a small area below the occiput.<xref ref-type="bibr" rid="article-26093.r7">[7]</xref>&#x000a0;While the precise mechanism of action of&#x000a0;ONS is still unclear, there has been a proposal that the continuous stimulation of the occipital nerves may produce diverse functional and metabolic changes in many brain regions, including pons, midbrain, and periaqueductal gray.<xref ref-type="bibr" rid="article-26093.r8">[8]</xref></p>
      </sec>
      <sec id="article-26093.s4" sec-type="Indications">
        <title>Indications</title>
        <p>ONS is indicated in primary (without&#x000a0;an underlying organic cause) and secondary (caused by an underlying condition, such as neck injuries, infections, or severe high blood pressure) intractable headache disorders including migraine and non-migrainous chronic headaches, and neuropathic pain in the occipital region.<xref ref-type="bibr" rid="article-26093.r9">[9]</xref>&#x000a0;Chronic headache is commonly defined as a headache on 15 or more days every month for longer than three months.<xref ref-type="bibr" rid="article-26093.r10">[10]</xref>&#x000a0;Patients with refractory headaches usually have failed results with conventional drugs either because of lack of effect, intolerable side effects, or contraindication to using.<xref ref-type="bibr" rid="article-26093.r10">[10]</xref></p>
        <p>Indications for occipital nerve stimulation include:&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>Occipital neuralgia is a neuropathic pain condition featuring severe sharp, shooting, or electric shock pain involving the occipital or suboccipital region, probably due to long-term compression of the C2 nerve. It is the third most common headache syndrome following migraine and tension-type headaches.<xref ref-type="bibr" rid="article-26093.r6">[6]</xref></p>
          </list-item>
          <list-item>
            <p>Chronic migraine. It&#x000a0;is the third most prevalent ailment in the world, affecting approximately one billion people worldwide.</p>
          </list-item>
          <list-item>
            <p>Cluster headache: An&#x000a0;excruciating attack of pain in 1 side of the head, often felt around the eye.</p>
          </list-item>
          <list-item>
            <p>Cervicogenic headache: A chronic headache that arises from the atlantooccipital and upper cervical joints.</p>
          </list-item>
          <list-item>
            <p>Hemicrania continua: It is a primary chronic daily headache disorder.</p>
          </list-item>
        </list>
        <p>Recently, this approach has been successful in treating a case of chemotherapy-related headaches.<xref ref-type="bibr" rid="article-26093.r11">[11]</xref></p>
      </sec>
      <sec id="article-26093.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>The contraindication of ONS are as follows<xref ref-type="bibr" rid="article-26093.r12">[12]</xref>:</p>
        <list list-type="order">
          <list-item>
            <p>If there is no improvement in the quality of life after a trial period, this procedure is not advised.</p>
          </list-item>
          <list-item>
            <p>If there is any concern about opioid misuse, then that may disqualify the patient from getting implant despite improvement with the trial block.</p>
          </list-item>
          <list-item>
            <p>Local infection</p>
          </list-item>
          <list-item>
            <p>Bleeding abnormalities</p>
          </list-item>
          <list-item>
            <p>Arnold-Chiari malformation</p>
          </list-item>
          <list-item>
            <p>An implanted electrical device (e.g., pacemaker, spinal cord stimulator) that may interfere with this therapy</p>
          </list-item>
          <list-item>
            <p>Pregnancy</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26093.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>The equipment required for ONS include<xref ref-type="bibr" rid="article-26093.r13">[13]</xref>:</p>
        <list list-type="bullet">
          <list-item>
            <p><italic toggle="yes">Electrodes and leads:&#x000a0;</italic>There are two types of leads; percutaneous (thin and cylindrical), and surgical or paddle (broad and flat). The percutaneous leads can be inserted using a needle, while paddle leads require a surgical method. The electric field around the percutaneous lead is circumferential; it gets directed towards one side in the case of paddle leads, which helps to stimulate even at low amperage, thereby prolonging battery life.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Anchors:</italic>&#x000a0;These help to attach leads and extensions to connective tissue.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Extensions:</italic>&#x000a0;These cables come in various lengths and are used to connect leads to the power source.</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">A power source</italic> (battery or internal pulse generator, IPG): It is usually implanted in a subcutaneous pocket away from the lead.&#x000a0;The battery life depends on the amplitude and number of hours of use the device has in a day. Usually, a lithium battery lasts for 3&#x000a0;to 5 years, and rechargeable batteries require replacement after 7&#x000a0;to 9 years.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26093.s7" sec-type="Preparation">
        <title>Preparation</title>
        <p><italic toggle="yes">Preprocedural planning.</italic>&#x000a0;A trial is necessary before permanent ONS implantation. In the trial period, leads are placed under the skin and connected to an external battery. The leads get inserted into the trailing cable. Stimulation is provided temporarily using a radiofrequency transmitter to different electrode combinations; this helps the patient to report the location, intensity, and sensation of stimulation. The trial period lasts for 4&#x000a0;to 7 days. During this period, the patient must maintain a headache diary. ONS is considered successful if there is more than fifty percent improvement in pain, or there is a decrease in the number of headache days or the patient reports improvement in the quality of life. The patients with successful block qualify for permanent implantation.<xref ref-type="bibr" rid="article-26093.r14">[14]</xref>&#x000a0;After the procedure, a complete healing time lasts for approximately six weeks. During that period, the patient is to avoid rigorous activity.</p>
        <p><italic toggle="yes">Local anesthesia vs. general anesthesia.</italic>&#x000a0;Weiner and Reed performed the placement of electrodes under local anesthesia. The advantage with local anesthesia is that it allows the patient to assess the site of paresthesia and thus verify electrode placement. This procedure can also take place under sedation with propofol (i.e., procedural sedation), and the staff can wake the patient to check areas of paresthesia intra-operatively. Recently, physicians have also been performing the procedure under general anesthesia in the prone position, which decreases the risk of lead migration.<xref ref-type="bibr" rid="article-26093.r15">[15]</xref></p>
        <p><italic toggle="yes">Positioning.</italic>&#x000a0;The procedure is possible in a lateral or prone position, depending on the entry point of incision.</p>
      </sec>
      <sec id="article-26093.s8" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>ONS is a minimally invasive technique in which a stimulator is implanted either unilaterally or bilaterally at the level of occipito-cervical junction. The stimulation parameters, like pulse width, amplitude, and frequency, can be adjusted to create paresthesia in the distribution of the occipital nerve. The procedure is performable under a lateral or medial approach.</p>
        <p><italic toggle="yes">Lateral approach</italic>. Weiner and Reed originally described the lateral approach in which the clinician makes an incision on the mastoid process, and the catheter was then subcutaneously advanced towards midline at the level of C1 with the help of fluoroscopy.<xref ref-type="bibr" rid="article-26093.r2">[2]</xref></p>
        <p><italic toggle="yes">Medial approach.</italic>&#x000a0;A 2 cm midline incision is made at the level of C1, and then leads are inserted laterally from the midpoint.</p>
        <p>The advantages of the medial approach include<xref ref-type="bibr" rid="article-26093.r16">[16]</xref>:&#x000a0;&#x000a0;</p>
        <list list-type="order">
          <list-item>
            <p>There is more subcutaneous fat in midline than laterally, which gives enough space to make a large subcutaneous pocket for placement of leads and adequate fixation to minimize dislocation.</p>
          </list-item>
          <list-item>
            <p>It is a more acceptable approach for patients who use spectacles and have complained of pain at the incision site.</p>
          </list-item>
          <list-item>
            <p>The bilateral electrodes are implantable through a single incision.</p>
          </list-item>
        </list>
        <p>Implant placement. The different positioning sites of the IPG include the upper buttock, abdomen, infrascapular region, and infraclavicular regions.<xref ref-type="bibr" rid="article-26093.r13">[13]</xref>&#x000a0;The advantage of placement in the upper buttock is that both electrode and generator can be placed in a prone position, whereas lateral or supine position is necessary for the other sites. It takes place under general anesthesia.</p>
        <p>Programming. Specific personnel appointed by the manufacturer do the device programming and maintenance.&#x000a0;</p>
        <p>A skull X-ray is taken after procedure completion to document the final lead position; this is also useful in the future to assess complications associated with lead migration or fracture.</p>
      </sec>
      <sec id="article-26093.s9" sec-type="Complications">
        <title>Complications</title>
        <p>The procedure-related complications are hardware-related and biological.</p>
        <p>
<italic toggle="yes">Hardware-related complications</italic>
</p>
        <p>Lead migration is by far the most frequent complication reported with ONS. In a retrospective analysis of fifteen patients treated for a medically refractory headache, Schwedt et al. reported the rate as high as 60&#x000a0;to 100%.<xref ref-type="bibr" rid="article-26093.r17">[17]</xref>&#x000a0;Moreover, this was also the most frequently reported adverse event (12 of 51 patients) in the ONSTIM randomized controlled trial on cephalgia.<xref ref-type="bibr" rid="article-26093.r18">[18]</xref>&#x000a0;The various studies on occipital neuralgia report an 8 to 10%&#x000a0; incidence of lead migration.<xref ref-type="bibr" rid="article-26093.r19">[19]</xref><xref ref-type="bibr" rid="article-26093.r20">[20]</xref><xref ref-type="bibr" rid="article-26093.r2">[2]</xref>&#x000a0;Of note, the occurrence of the complications is reducible by decreasing mechanical stress on the leads by avoiding excessive neck movement. Moreover, these complications are usually related to severe trauma, such as a major car accident. Other methods described in the literature to prevent lead migration include the use of silicone glue, soft neck collars, and the use of a midline approach.<xref ref-type="bibr" rid="article-26093.r13">[13]</xref>&#x000a0;The other hardware-related complications include lead fracture and malfunction&#x000a0;and repositioning of the generator.<xref ref-type="bibr" rid="article-26093.r17">[17]</xref><xref ref-type="bibr" rid="article-26093.r18">[18]</xref><xref ref-type="bibr" rid="article-26093.r2">[2]</xref><xref ref-type="bibr" rid="article-26093.r9">[9]</xref></p>
        <p>
<italic toggle="yes">Biological complications</italic>
</p>
        <p>Patients treated with implanted neuromodulation devices often report pain related to the site of device components.<xref ref-type="bibr" rid="article-26093.r21">[21]</xref>&#x000a0;Saper et al. reported two cases of pain, one over the IPG site and other burning pain over the lead site. The other complications reported in retrospective studies include muscle spasms, wound dehiscence, infection (up to 4%), and skin erosion.<xref ref-type="bibr" rid="article-26093.r18">[18]</xref><xref ref-type="bibr" rid="article-26093.r22">[22]</xref> Infection can be prevented by prophylactic antibiotics, maintaining asepsis throughout the procedure, and trimming of occipital region hair using clippers.</p>
        <p>Some other complications associated with ONS include device malfunction, compliance issues, ineffective stimulation, and device shock.<xref ref-type="bibr" rid="article-26093.r21">[21]</xref></p>
      </sec>
      <sec id="article-26093.s10" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>Chronic headache affects 3&#x000a0;to 5% of the world population&#x000a0;and ranks third highest cause of years lost due to disability.<xref ref-type="bibr" rid="article-26093.r23">[23]</xref> Recent advances in the medical management of headache disorders have led to the effective treatment of the majority of patients. However, a small percentage of these patients do not respond to conventional treatment options. While ONS could be an interesting option in the treatment of this subset of patients, there is only limited scientific evidence regarding its effectiveness as the studies conducted so far have enrolled a small number of patients and are uncontrolled investigations. Furthermore, there is little data on the long-term results. A&#x000a0;multicentric, controlled (ONS compared to the optimal medical management), and randomized study organized by the Nantes University Hospital is ongoing. The estimated study completion date is the end of 2022, and its&#x000a0;results should clarify many doubts about the actual utility of the technique.</p>
      </sec>
      <sec id="article-26093.s11" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>A systemic review on chronic migraine demonstrated that the short term effect of ONS might be modest but still clinically significant in patients with refractory headache.<xref ref-type="bibr" rid="article-26093.r24">[24]</xref>&#x000a0;While some patients apparently experienced significant improvement, the data is limited. At the same time, it correlates with the procedure and device-related complications. Currently, ONS seems a valuable option for patients who have failed all conventional treatment, but further studies are needed to evaluate the safety and efficacy. Due to the lack of conclusive data, currently, the use of ONS should be based on individual preference and treatment response.&#x000a0;</p>
      </sec>
      <sec id="article-26093.s12">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26093&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26093">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26093/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26093">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26093.s13">
        <title>References</title>
        <ref id="article-26093.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Picaza</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Hunter</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Cannon</surname>
                <given-names>BW</given-names>
              </name>
            </person-group>
            <article-title>Pain suppression by peripheral nerve stimulation. Chronic effects of implanted devices.</article-title>
            <source>Appl Neurophysiol</source>
            <string-date>1977-1978</string-date>
            <volume>40</volume>
            <issue>2-4</issue>
            <fpage>223</fpage>
            <page-range>223-34</page-range>
            <pub-id pub-id-type="pmid">309314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weiner</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>KL</given-names>
              </name>
            </person-group>
            <article-title>Peripheral neurostimulation for control of intractable occipital neuralgia.</article-title>
            <source>Neuromodulation</source>
            <year>1999</year>
            <month>Jul</month>
            <volume>2</volume>
            <issue>3</issue>
            <fpage>217</fpage>
            <page-range>217-21</page-range>
            <pub-id pub-id-type="pmid">22151211</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Keifer</surname>
                <given-names>OP</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Campbell</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bezchlibnyk</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Boulis</surname>
                <given-names>NM</given-names>
              </name>
            </person-group>
            <article-title>Occipital Nerve Stimulation for the Treatment of Refractory Occipital Neuralgia: A Case Series.</article-title>
            <source>World Neurosurg</source>
            <year>2017</year>
            <month>Sep</month>
            <volume>105</volume>
            <fpage>599</fpage>
            <page-range>599-604</page-range>
            <pub-id pub-id-type="pmid">28634063</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodrigo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Acin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Bermejo</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Occipital Nerve Stimulation for Refractory Chronic Migraine: Results of a Long-Term Prospective Study.</article-title>
            <source>Pain Physician</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>20</volume>
            <issue>1</issue>
            <fpage>E151</fpage>
            <page-range>E151-E159</page-range>
            <pub-id pub-id-type="pmid">28072807</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Watkins</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Matharu</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Treatment of intractable chronic cluster headache by occipital nerve stimulation: a cohort of 51 patients.</article-title>
            <source>Eur J Neurol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>381</fpage>
            <page-range>381-390</page-range>
            <pub-id pub-id-type="pmid">27995704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Liu</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jiao</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Ji</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Unilateral occipital nerve stimulation for bilateral occipital neuralgia: a case report and literature review.</article-title>
            <source>J Pain Res</source>
            <year>2017</year>
            <volume>10</volume>
            <fpage>229</fpage>
            <page-range>229-232</page-range>
            <pub-id pub-id-type="pmid">28176938</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choi</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Jeon</surname>
                <given-names>SR</given-names>
              </name>
            </person-group>
            <article-title>Neuralgias of the Head: Occipital Neuralgia.</article-title>
            <source>J Korean Med Sci</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>479</fpage>
            <page-range>479-88</page-range>
            <pub-id pub-id-type="pmid">27051229</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bari</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Pouratian</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Brain imaging correlates of peripheral nerve stimulation.</article-title>
            <source>Surg Neurol Int</source>
            <year>2012</year>
            <volume>3</volume>
            <issue>Suppl 4</issue>
            <fpage>S260</fpage>
            <page-range>S260-8</page-range>
            <pub-id pub-id-type="pmid">23230531</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palmisani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Al-Kaisy</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Arcioni</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Negro</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Lambru</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bandikatla</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Carson</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Martelletti</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>A six year retrospective review of occipital nerve stimulation practice--controversies and challenges of an emerging technique for treating refractory headache syndromes.</article-title>
            <source>J Headache Pain</source>
            <year>2013</year>
            <month>Aug</month>
            <day>06</day>
            <volume>14</volume>
            <issue>1</issue>
            <fpage>67</fpage>
            <pub-id pub-id-type="pmid">23919570</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Schoenen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ferrari</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Towards a definition of intractable headache for use in clinical practice and trials.</article-title>
            <source>Cephalalgia</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>26</volume>
            <issue>9</issue>
            <fpage>1168</fpage>
            <page-range>1168-70</page-range>
            <pub-id pub-id-type="pmid">16919073</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abd-Elsayed</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pahapill</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Successful Treatment of Chemotherapy-Induced Headaches With Occipital Nerve Stimulation: A Case Report.</article-title>
            <source>Neuromodulation</source>
            <year>2020</year>
            <month>Aug</month>
            <volume>23</volume>
            <issue>6</issue>
            <fpage>881</fpage>
            <page-range>881-882</page-range>
            <pub-id pub-id-type="pmid">31755627</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>Reed</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Deer</surname>
                <given-names>TR</given-names>
              </name>
              <name>
                <surname>Slavin</surname>
                <given-names>KV</given-names>
              </name>
              <name>
                <surname>Huh</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Sharan</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Narouze</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mogilner</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Trentman</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Ordia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Vaisman</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Goldstein</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mekhail</surname>
                <given-names>N</given-names>
              </name>
            </person-group>
            <article-title>Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: long-term results from a randomized, multicenter, double-blinded, controlled study.</article-title>
            <source>Cephalalgia</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>35</volume>
            <issue>4</issue>
            <fpage>344</fpage>
            <page-range>344-58</page-range>
            <pub-id pub-id-type="pmid">25078718</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trentman</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Occipital nerve stimulation: technical and surgical aspects of implantation.</article-title>
            <source>Headache</source>
            <year>2008</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>319</fpage>
            <page-range>319-27</page-range>
            <pub-id pub-id-type="pmid">18234049</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lambru</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Matharu</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Occipital nerve stimulation in primary headache syndromes.</article-title>
            <source>Ther Adv Neurol Disord</source>
            <year>2012</year>
            <month>Jan</month>
            <volume>5</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-67</page-range>
            <pub-id pub-id-type="pmid">22276076</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Trentman</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>RS</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Dormer</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Vargas</surname>
                <given-names>BB</given-names>
              </name>
            </person-group>
            <article-title>Occipital nerve stimulator placement under general anesthesia: initial experience with 5 cases and review of the literature.</article-title>
            <source>J Neurosurg Anesthesiol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>158</fpage>
            <page-range>158-62</page-range>
            <pub-id pub-id-type="pmid">19816202</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paemeleire</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Bartsch</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Occipital nerve stimulation for headache disorders.</article-title>
            <source>Neurotherapeutics</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>7</volume>
            <issue>2</issue>
            <fpage>213</fpage>
            <page-range>213-9</page-range>
            <pub-id pub-id-type="pmid">20430321</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Schwedt</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Hentz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Trentman</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Zimmerman</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Occipital nerve stimulation for chronic headache--long-term safety and efficacy.</article-title>
            <source>Cephalalgia</source>
            <year>2007</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-7</page-range>
            <pub-id pub-id-type="pmid">17257236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Saper</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Dodick</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Silberstein</surname>
                <given-names>SD</given-names>
              </name>
              <name>
                <surname>McCarville</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sun</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
              <collab>ONSTIM Investigators</collab>
            </person-group>
            <article-title>Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study.</article-title>
            <source>Cephalalgia</source>
            <year>2011</year>
            <month>Feb</month>
            <volume>31</volume>
            <issue>3</issue>
            <fpage>271</fpage>
            <page-range>271-85</page-range>
            <pub-id pub-id-type="pmid">20861241</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnstone</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Sundaraj</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Occipital nerve stimulation for the treatment of occipital neuralgia-eight case studies.</article-title>
            <source>Neuromodulation</source>
            <year>2006</year>
            <month>Jan</month>
            <volume>9</volume>
            <issue>1</issue>
            <fpage>41</fpage>
            <page-range>41-7</page-range>
            <pub-id pub-id-type="pmid">22151592</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Melvin</surname>
                <given-names>EA</given-names>
              </name>
              <name>
                <surname>Jordan</surname>
                <given-names>FR</given-names>
              </name>
              <name>
                <surname>Weiner</surname>
                <given-names>RL</given-names>
              </name>
              <name>
                <surname>Primm</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Using peripheral stimulation to reduce the pain of C2-mediated occipital headaches: a preliminary report.</article-title>
            <source>Pain Physician</source>
            <year>2007</year>
            <month>May</month>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>453</fpage>
            <page-range>453-60</page-range>
            <pub-id pub-id-type="pmid">17525779</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Doran</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ward</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Paskhover</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Umanoff</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mammis</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Investigating Complications Associated With Occipital Nerve Stimulation: A MAUDE Study.</article-title>
            <source>Neuromodulation</source>
            <year>2018</year>
            <month>Apr</month>
            <volume>21</volume>
            <issue>3</issue>
            <fpage>296</fpage>
            <page-range>296-301</page-range>
            <pub-id pub-id-type="pmid">29345415</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Paemeleire</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Van Buyten</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Van Buynder</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Alicino</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Van Maele</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Smet</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Goadsby</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Phenotype of patients responsive to occipital nerve stimulation for refractory head pain.</article-title>
            <source>Cephalalgia</source>
            <year>2010</year>
            <month>Jun</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>662</fpage>
            <page-range>662-73</page-range>
            <pub-id pub-id-type="pmid">20511204</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rizzoli</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Mullally</surname>
                <given-names>WJ</given-names>
              </name>
            </person-group>
            <article-title>Headache.</article-title>
            <source>Am J Med</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>131</volume>
            <issue>1</issue>
            <fpage>17</fpage>
            <page-range>17-24</page-range>
            <pub-id pub-id-type="pmid">28939471</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26093.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chen</surname>
                <given-names>YF</given-names>
              </name>
              <name>
                <surname>Bramley</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Unwin</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Hanu-Cernat</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Dretzke</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Bayliss</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cummins</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lilford</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Occipital nerve stimulation for chronic migraine--a systematic review and meta-analysis.</article-title>
            <source>PLoS One</source>
            <year>2015</year>
            <volume>10</volume>
            <issue>3</issue>
            <fpage>e0116786</fpage>
            <pub-id pub-id-type="pmid">25793740</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
